Oxoplan 50mg Injection

About

Oxoplan 50mg Injection contains Oxaliplatin, a platinum-based alkylating agent used in cancer chemotherapy. It functions by forming covalent bonds with DNA, leading to the formation of platinum-DNA adducts. These adducts interfere with DNA replication and transcription, ultimately triggering cell cycle arrest and programmed cell death (apoptosis) in rapidly dividing cancer cells. Oxaliplatin is particularly distinguished by its activity against colorectal cancer and its unique toxicity profile, including a characteristic acute peripheral neuropathy often exacerbated by cold exposure. It is typically administered intravenously as part of combination regimens, such as FOLFOX, to enhance its efficacy against various gastrointestinal malignancies. Its distinct mechanism helps overcome resistance to other platinum agents.

Uses

• Metastatic colorectal cancer
• Adjuvant treatment of colon cancer
• Gastric adenocarcinoma
• Pancreatic adenocarcinoma

Directions For Use

Administer intravenously over 2 hours, typically every 2 weeks, under strict medical supervision. Avoid exposure to cold during and after infusion.

Benefits

• Highly effective in colorectal cancer.
• Induces DNA damage and apoptosis in cancer cells.
• Less nephrotoxic and ototoxic than cisplatin.
• Synergistic with fluoropyrimidines.
• Improves disease-free survival in adjuvant settings.
• Key component of standard chemotherapy regimens.

Side Effects

• Peripheral neuropathy (acute and chronic, cold-induced)
• Myelosuppression (thrombocytopenia, neutropenia, anemia)
• Nausea and vomiting (often severe, requiring antiemetics)
• Diarrhea/constipation
• Fatigue/asthenia
• Stomatitis/mucositis
• Hypersensitivity reactions (infusion-related)
• Liver function test abnormalities
• Abdominal pain
• Dysgeusia
• Hair thinning (rare)
• Renal dysfunction (rare)

Safety Measures

• Alcohol - Avoid or limit alcohol, as it may exacerbate gastrointestinal side effects or liver toxicity, which can be associated with this medication.
• Pregnancy - Contraindicated in pregnancy due to potential fetal harm. Effective contraception is required during treatment and for a period after.
• Breastfeeding - Not recommended during breastfeeding due to potential harm to the infant; it is unknown if the drug is excreted in human milk.
• Liver - Use with caution in hepatic impairment; monitor liver function closely as dose adjustments may be necessary.
• Kidney - Use with caution in renal impairment; dose adjustments may be necessary based on creatinine clearance.
• Lung - Rarely, interstitial lung disease or pulmonary fibrosis can occur; monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.